158 related articles for article (PubMed ID: 28566761)
41. CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells
Reimer J; Knöß S; Labuhn M; Charpentier EM; Göhring G; Schlegelberger B; Klusmann JH; Heckl D
Haematologica; 2017 Sep; 102(9):1558-1566. PubMed ID: 28572162
[TBL] [Abstract][Full Text] [Related]
42. CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice.
Ohmori T; Nagao Y; Mizukami H; Sakata A; Muramatsu SI; Ozawa K; Tominaga SI; Hanazono Y; Nishimura S; Nureki O; Sakata Y
Sci Rep; 2017 Jun; 7(1):4159. PubMed ID: 28646206
[TBL] [Abstract][Full Text] [Related]
43. Computational Prediction of CRISPR/Cas9 Target Sites Reveals Potential Off-Target Risks in Human and Mouse.
Wang Q; Ui-Tei K
Methods Mol Biol; 2017; 1630():43-53. PubMed ID: 28643248
[TBL] [Abstract][Full Text] [Related]
44. CRISPR-GE: A Convenient Software Toolkit for CRISPR-Based Genome Editing.
Xie X; Ma X; Zhu Q; Zeng D; Li G; Liu YG
Mol Plant; 2017 Sep; 10(9):1246-1249. PubMed ID: 28624544
[No Abstract] [Full Text] [Related]
45. CRISPR/Cas9: Transcending the Reality of Genome Editing.
Chira S; Gulei D; Hajitou A; Zimta AA; Cordelier P; Berindan-Neagoe I
Mol Ther Nucleic Acids; 2017 Jun; 7():211-222. PubMed ID: 28624197
[TBL] [Abstract][Full Text] [Related]
46. Production of Guide RNAs
Zhang T; Gao Y; Wang R; Zhao Y
Bio Protoc; 2017 Feb; 7(4):. PubMed ID: 28603751
[TBL] [Abstract][Full Text] [Related]
47. Progress and Application of CRISPR/Cas Technology in Biological and Biomedical Investigation.
Lin J; Zhou Y; Liu J; Chen J; Chen W; Zhao S; Wu Z; Wu N
J Cell Biochem; 2017 Oct; 118(10):3061-3071. PubMed ID: 28590031
[TBL] [Abstract][Full Text] [Related]
48. CRISPR/Cas9-Mediated In Vitro Mutagenesis in GC-Like B Cells.
Chu VT; Graf R; Rajewsky K
Methods Mol Biol; 2017; 1623():135-145. PubMed ID: 28589354
[TBL] [Abstract][Full Text] [Related]
49. Long-Term Assessment of AAV-Mediated Zinc Finger Nuclease Expression in the Mouse Brain.
Zahur M; Tolö J; Bähr M; Kügler S
Front Mol Neurosci; 2017; 10():142. PubMed ID: 28588449
[TBL] [Abstract][Full Text] [Related]
50. Engineered Cpf1 variants with altered PAM specificities.
Gao L; Cox DBT; Yan WX; Manteiga JC; Schneider MW; Yamano T; Nishimasu H; Nureki O; Crosetto N; Zhang F
Nat Biotechnol; 2017 Aug; 35(8):789-792. PubMed ID: 28581492
[TBL] [Abstract][Full Text] [Related]
51. Sudden cardiac death and Ethical issues of CRISPR technology.
Vetter N
Br Med Bull; 2017 Jun; 122(1):1-3. PubMed ID: 28575221
[No Abstract] [Full Text] [Related]
52. CRISPR-Cas Genome Surgery in Ophthalmology.
DiCarlo JE; Sengillo JD; Justus S; Cabral T; Tsang SH; Mahajan VB
Transl Vis Sci Technol; 2017 May; 6(3):13. PubMed ID: 28573077
[TBL] [Abstract][Full Text] [Related]
53. A CRISPR Cas9 high-throughput genome editing toolkit for kinetoplastids.
Beneke T; Madden R; Makin L; Valli J; Sunter J; Gluenz E
R Soc Open Sci; 2017 May; 4(5):170095. PubMed ID: 28573017
[TBL] [Abstract][Full Text] [Related]
54. Genome Editing Mediated by Primordial Germ Cell in Chicken.
Han JY; Lee HJ
Methods Mol Biol; 2017; 1630():153-163. PubMed ID: 28643257
[TBL] [Abstract][Full Text] [Related]
55. Generation of an induced pluripotent stem cell line (SDQLCHi009-A) from a patient with 47,XXY and ornithine transcarbamylase deficiency carrying a hemizygote mutation in OTC.
Yang X; Yan B; Zhang H; Ma Y; Zhou Q; Li Y; Guan J; Wang D; Liu Y; Gai Z
Stem Cell Res; 2020 Mar; 43():101704. PubMed ID: 32014801
[TBL] [Abstract][Full Text] [Related]
56. Intrahepatic Administration of Human Liver Stem Cells in Infants with Inherited Neonatal-Onset Hyperammonemia: A Phase I Study.
Spada M; Porta F; Righi D; Gazzera C; Tandoi F; Ferrero I; Fagioli F; Sanchez MBH; Calvo PL; Biamino E; Bruno S; Gunetti M; Contursi C; Lauritano C; Conio A; Amoroso A; Salizzoni M; Silengo L; Camussi G; Romagnoli R
Stem Cell Rev Rep; 2020 Feb; 16(1):186-197. PubMed ID: 31792768
[TBL] [Abstract][Full Text] [Related]
57. Transplantation of Gene-Edited Hepatocyte-like Cells Modestly Improves Survival of Arginase-1-Deficient Mice.
Sin YY; Ballantyne LL; Richmond CR; Funk CD
Mol Ther Nucleic Acids; 2018 Mar; 10():122-130. PubMed ID: 29499927
[TBL] [Abstract][Full Text] [Related]
58. Emerging and potential use of CRISPR in human liver disease.
Adlat S; Vázquez Salgado AM; Lee M; Yin D; Wangensteen KJ
Hepatology; 2023 Aug; ():. PubMed ID: 37607734
[TBL] [Abstract][Full Text] [Related]
59. Review: Research progress of adipose-derived stem cells in the treatment of chronic wounds.
Hao Z; Qi W; Sun J; Zhou M; Guo N
Front Chem; 2023; 11():1094693. PubMed ID: 36860643
[TBL] [Abstract][Full Text] [Related]
60. Modelling urea cycle disorders using iPSCs.
Duff C; Baruteau J
NPJ Regen Med; 2022 Sep; 7(1):56. PubMed ID: 36163209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
